Vascular permeability increase as induced by histamine or bradykinin is enhanced by advanced glycation endproducts (AGEs).
Advanced glycation endproducts (AGEs) may enhance vascular permeability in diabetic subjects. To test this hypothesis, AGEs were prepared in the presence of albumin (AGE-Alb). Control albumin (Alb) and AGE-Alb were then labeled with FITC (fluoresceinisothiocyanate) and injected i.v. into anesthetized hamsters at a dose of 7 mg/100 g B.W. Normal hamsters were given FITC-Alb or FITC-AGE-Alb and FITC-dextran. Vascular permeability changes were measured by direct intravital microscopy of the hamster cheek pouch preparations in fluorescent light and recorded as number of sites (=leaks) with extravasation of FITC-labeled albumin in postcapillary venules. No changes were seen during 1 hour after i.v. injection of FITC-Alb or FITC-AGE-Alb. Repeated local application of histamine 5 x 10(6) M or bradykinin 5 x 10(7) M to the cheek pouch for 5 min with 30-min intervals induced reversible increases in vascular permeability in all hamsters. Maximal number of leaks/cm2 before and at 30 and 60 min after FITC-Alb-injection and histamine application was 257 +/- 6 (SEM), 243 +/- 6 and 231 +/- 6 leaks/cm2 in the FITC-Alb-group and 258 + 6 (SEM), 302 +/- 12 and 316 +/- 11 leaks/cm2 in the FITCAGE-Alb-group, respectively, (P < 0.05 at 30 and 60 min). Similar results were seen with bradykinin. Our conclusions showed that i.v.-injected AGEs augmented the histamine- and bradykinin-induced increase in vascular permeability by 34% and 46%.
Svensjö
E
E
Instituto do Coração, Universidade de São Paulo, SP, Brazil.
Cyrino
F
F
Michoud
E
E
Ruggiero
D
D
Bouskela
E
E
Wiernsperger
N
N
D000418:Albumins; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects*; D006224:Cricetinae; D003911:Dextrans; D004357:Drug Synergism; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives; D005456:Fluorescent Dyes; D017127:Glycation End Products, Advanced / Q000008:administration & dosage / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology*; D008297:Male; D008647:Mesocricetus; D009061:Mouth Mucosa / Q000098:blood supply / Q000187:drug effects
D000418:Albumins; D003911:Dextrans; D005456:Fluorescent Dyes; D017127:Glycation End Products, Advanced; C015219:fluorescein isothiocyanate dextran; D006632:Histamine; D016650:Fluorescein-5-isothiocyanate; D001920:Bradykinin